Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 2/20 | 0.54 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.54 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.51 |
| ▸ | PARP1 | P09874 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | DRD2 | P14416 | 2/20 | 0.45 |
| ▸ | DRD3 | P35462 | 2/20 | 0.45 |
| ▸ | IKBKB | O14920 | 6/20 | 0.44 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.44 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.44 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.43 |
| ▸ | CFD | P00746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10380819 | 0.93 | ROCK2 (0.58) | ROCK2ROCK1CHRM3PARP1MEN1 | |
| SCHEMBL13766311 | 0.90 | PARP1 (0.61) | ROCK2ROCK1CHRM3PARP1MEN1 | |
| SCHEMBL13005419 | 0.88 | ROCK2 (0.52) | ROCK2ROCK1PARP1MEN1KMT2A | |
| SCHEMBL17790228 | 0.82 | ROCK2 (0.61) | ROCK2ROCK1PARP1DRD2DRD3 | |
| SCHEMBL279575 | 0.81 | HPGD (0.59) | ROCK2ROCK1PARP1DRD2SCN9A | |
| SCHEMBL17788671 | 0.80 | ROCK2 (0.59) | ROCK2ROCK1PARP1DRD2DRD3 | |
| SCHEMBL18901294 | 0.79 | ROCK2 (0.58) | ROCK2ROCK1PARP1DRD2DRD3 | |
| SCHEMBL8274391 | 0.78 | ADRB1 (0.60) | ROCK2ROCK1PARP1IKBKBSCN9A | |
| SCHEMBL31188482 | 0.78 | ADRB1 (0.60) | ROCK2ROCK1PARP1IKBKBSCN9A | |
| SCHEMBL5088410 | 0.78 | ADRB1 (0.60) | ROCK2ROCK1PARP1IKBKBSCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7851637-B2 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | INFINITY PHARMACEUTICALS, INC. (US) | 2010-12-14 | — | — | US | disclosed |